
Spero Health
Free, confidential, no commitment
Full Address
102 Enoch Boulevard
Savannah, Tennessee 38372
Phone Numbers
Main: 731-400-4091
Hours
24/7 - Always Available
Spero Health
102 Enoch Boulevard, Savannah, TN 38372

Spero Health, located in Savannah, TN, is dedicated to providing outpatient treatment for substance use, with an emphasis on delivering high-quality care that is tailored to each individual's needs. At this facility, clients can access various services, including medication-assisted treatment options such as methadone, buprenorphine, or naltrexone, alongside regular outpatient counseling. The center employs a diverse array of therapeutic strategies, incorporating methods like anger management, brief interventions, and cognitive-behavioral therapy to support recovery. Spero Health is committed to serving a wide demographic, welcoming adult men and women, including those who have faced intimate partner or domestic violence. With a strong focus on personalized care, Spero Health strives to guide individuals—both adults and young adults—through their unique paths to recovery, ensuring that each client receives the support they need to make meaningful progress on their journey.
This facility accepts various insurance plans. Contact them directly to verify coverage for your specific plan.
Spero Health
102 Enoch Boulevard, Savannah, TN 38372
Free, confidential, no commitment
| Type of Care | Substance use treatment |
| Service Settings | Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment |
| Medications Offered | Buprenorphine used in Treatment, Naltrexone used in Treatment |
Accepted Payment Methods
Age Groups
Gender
Based on available information, this facility accepts Federal military insurance (e.g., TRICARE), Medicaid, Medicare, Private health insurance. However, insurance coverage can vary by plan and individual circumstances. Please contact the facility directly to verify if your specific insurance plan is accepted and what services are covered.



